These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22784847)

  • 21. Potential role of two novel agonists of thyroid hormone receptor-β on liver regeneration.
    Perra A; Kowalik MA; Cabras L; Runfola M; Sestito S; Migliore C; Giordano S; Chiellini G; Rapposelli S; Columbano A
    Cell Prolif; 2020 May; 53(5):e12808. PubMed ID: 32347601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ligand induced interaction of thyroid hormone receptor beta with its coregulators.
    Valadares NF; Polikarpov I; Garratt RC
    J Steroid Biochem Mol Biol; 2008 Dec; 112(4-5):205-12. PubMed ID: 19000767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A TRbeta-selective agonist confers resistance to diet-induced obesity.
    Amorim BS; Ueta CB; Freitas BC; Nassif RJ; Gouveia CH; Christoffolete MA; Moriscot AS; Lancelloti CL; Llimona F; Barbeiro HV; de Souza HP; Catanozi S; Passarelli M; Aoki MS; Bianco AC; Ribeiro MO
    J Endocrinol; 2009 Nov; 203(2):291-9. PubMed ID: 19713219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid hormone analogs for the treatment of dyslipidemia: past, present, and future.
    Delitala AP; Delitala G; Sioni P; Fanciulli G
    Curr Med Res Opin; 2017 Nov; 33(11):1985-1993. PubMed ID: 28498022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical Hybridization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for Metabolic Disease.
    Finan B; Clemmensen C; Zhu Z; Stemmer K; Gauthier K; Müller L; De Angelis M; Moreth K; Neff F; Perez-Tilve D; Fischer K; Lutter D; Sánchez-Garrido MA; Liu P; Tuckermann J; Malehmir M; Healy ME; Weber A; Heikenwalder M; Jastroch M; Kleinert M; Jall S; Brandt S; Flamant F; Schramm KW; Biebermann H; Döring Y; Weber C; Habegger KM; Keuper M; Gelfanov V; Liu F; Köhrle J; Rozman J; Fuchs H; Gailus-Durner V; Hrabě de Angelis M; Hofmann SM; Yang B; Tschöp MH; DiMarchi R; Müller TD
    Cell; 2016 Oct; 167(3):843-857.e14. PubMed ID: 27720451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The lipoprotein lipase inhibitor ANGPTL3 is negatively regulated by thyroid hormone.
    Fugier C; Tousaint JJ; Prieur X; Plateroti M; Samarut J; Delerive P
    J Biol Chem; 2006 Apr; 281(17):11553-9. PubMed ID: 16505486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the thyroid hormone receptor agonist GC-1 on metabolic rate and cholesterol in rats and primates: selective actions relative to 3,5,3'-triiodo-L-thyronine.
    Grover GJ; Egan DM; Sleph PG; Beehler BC; Chiellini G; Nguyen NH; Baxter JD; Scanlan TS
    Endocrinology; 2004 Apr; 145(4):1656-61. PubMed ID: 14701670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and synthesis of a novel series of [1-(4-hydroxy-benzyl)-1H-indol-5-yloxy]-acetic acid compounds as potent, selective, thyroid hormone receptor β agonists.
    Burkholder TP; Cunningham BE; Clayton JR; Lander PA; Brown ML; Doti RA; Durst GL; Montrose-Rafizadeh C; King C; Osborne HE; Amos RM; Zink RW; Stramm LE; Burris TP; Cardona G; Konkol DL; Reidy C; Christe ME; Genin MJ
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1377-80. PubMed ID: 25752984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exciting advances in GPCR-based drugs discovery for treating metabolic disease and future perspectives.
    Quiñones M; Fernø J; Diéguez C; Nogueiras R; Al-Massadi O
    Expert Opin Drug Discov; 2019 May; 14(5):421-431. PubMed ID: 30821530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of maternal levels of thyroid hormone (TH) on the hypothalamus-pituitary-thyroid set point: studies in TH receptor beta knockout mice.
    Alonso M; Goodwin C; Liao X; Page D; Refetoff S; Weiss RE
    Endocrinology; 2007 Nov; 148(11):5305-12. PubMed ID: 17690164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid hormone ligands and metabolic diseases.
    Malm J
    Curr Pharm Des; 2004; 10(28):3525-32. PubMed ID: 15579049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological characterization of a heterodimer-selective retinoid X receptor modulator: potential benefits for the treatment of type 2 diabetes.
    Leibowitz MD; Ardecky RJ; Boehm MF; Broderick CL; Carfagna MA; Crombie DL; D'Arrigo J; Etgen GJ; Faul MM; Grese TA; Havel H; Hein NI; Heyman RA; Jolley D; Klausing K; Liu S; Mais DE; Mapes CM; Marschke KB; Michellys PY; Montrose-Rafizadeh C; Ogilvie KM; Pascual B; Rungta D; Tyhonas JS; Urcan MS; Wardlow M; Yumibe N; Reifel-Miller A
    Endocrinology; 2006 Feb; 147(2):1044-53. PubMed ID: 16269450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Marked potentiation of the dominant negative action of a mutant thyroid hormone receptor beta in mice by the ablation of one wild-type beta allele.
    Suzuki H; Zhang XY; Forrest D; Willingham MC; Cheng SY
    Mol Endocrinol; 2003 May; 17(5):895-907. PubMed ID: 12576488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and pharmacological characterization of 1-benzyl-4-aminoindole-based thyroid hormone receptor β agonists.
    Takahashi N; Maeda K; Asano Y; Watanabe N
    Bioorg Med Chem; 2014 Jan; 22(1):488-98. PubMed ID: 24290064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid Hormone Receptor-β Agonists in NAFLD Therapy: Possibilities and Challenges.
    Li L; Song Y; Shi Y; Sun L
    J Clin Endocrinol Metab; 2023 Jun; 108(7):1602-1613. PubMed ID: 36746649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo activity of the thyroid hormone receptor beta- and α-selective agonists GC-24 and CO23 on rat liver, heart, and brain.
    Grijota-Martínez C; Samarut E; Scanlan TS; Morte B; Bernal J
    Endocrinology; 2011 Mar; 152(3):1136-42. PubMed ID: 21239431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of thyroid hormone analogs on lipid metabolism and thermogenesis.
    Ribeiro MO
    Thyroid; 2008 Feb; 18(2):197-203. PubMed ID: 18279020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of beta 3-adrenoceptor agonists for the treatment of obesity and diabetes--an update.
    Weyer C; Gautier JF; Danforth E
    Diabetes Metab; 1999 Mar; 25(1):11-21. PubMed ID: 10335419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor β.
    Park JW; Zhao L; Willingham MC; Cheng SY
    Mol Carcinog; 2017 Feb; 56(2):489-498. PubMed ID: 27254276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.